Karen Martel, CEO of Midlife Solutions, joins Stephanie Gambetta for a candid conversation about perimenopause, menopause, hormone replacement therapy, peptides, GLP-1s, and what actually changes in a woman’s body during midlife. Karen shares how her own experience being pushed into early menopause at 42 changed the direction of her career, despite already working as a nutritionist and doing everything she thought was “right.” She and Stephanie break down the early signs of perimenopause, progesterone and estrogen loss, stubborn midlife weight gain, brain fog, mood changes, and why you can’t always diet, exercise, or biohack your way out of hormonal changes. Stephanie also opens up about her own HRT journey at 51, including progesterone, estrogen, testosterone pellets, and the changes she’s currently navigating. Together, she and Karen discuss why HRT and peptides can work together rather than compete, combining GLP-1s with optimized hormones, microdosing, food noise, preserving muscle, thyroid health, and why some women plateau on GLP-1s even at higher doses. They also get into starting HRT later in life, overdoing biohacking, wearable data, DEXA scans, peptide safety, and why women need individualized protocols instead of copying whatever someone else is taking online. Karen and Stephanie also challenge the idea that suffering through menopause deserves a badge of honor. The goal isn’t perfection or doing every wellness trend imaginable. It’s understanding your body, finding the right tools, and building a sustainable approach that helps you feel strong, confident, and healthy through the second half of life. Use code LOOP10 for 10% off at Midlife Solutions. Shop Midlife Solutions This episode is for educational purposes only and should not be considered medical advice. Always consult qualified healthcare professionals before beginning or changing hormones, medications, peptides, supplements, or other treatments. Peptides, Hormones & Compounds Discussed Hormone Replacement Therapy (HRT)EstrogenProgesteroneTestosteroneGLP-1 receptor agonistsRetatrutideGHK-CuTB-500BPC-157MOTS-cTesamorelinThyroid medication